Effect of hypofibrinogenemia on obstetrical disseminated intravascular coagulation in Japan in 2018: a multicenter retrospective cohort study

被引:0
|
作者
Mamoru Morikawa
Shigetaka Matsunaga
Shintaro Makino
Yoshiharu Takeda
Hironobu Hyoudo
Masafumi Nii
Mariko Serizawa
Atsuo Itakura
Tomoko Adachi
Takao Kobayashi
机构
[1] Hokkaido University Graduate School of Medicine,Department of Obstetrics and Gynecology
[2] Saitama Medical University,Department of Obstetrics and Gynecology, Center for Maternal, Fetal, and Neonatal Medicine, Saitama Medical Center
[3] Juntendo University Urayasu Hospital,Department of Obstetrics and Gynecology
[4] Aiiku Maternal and Child Health Center,Department of Obstetrics and Gynecology
[5] Aiiku Hospital,Department of Obstetrics and Gynecology
[6] Tokyo Metropolitan Bokutoh Hospital,Department of Obstetrics and Gynecology
[7] Mie University Graduate School of Medicine,Department of Obstetrics and Gynecology
[8] Hamamatsu Medical Center,Department of Obstetrics and Gynecology
[9] Juntendo University Graduate School of Medicine,undefined
[10] The Japan Society of Obstetrical,undefined
[11] Gynecological and Neonatal Hematology,undefined
来源
International Journal of Hematology | 2021年 / 114卷
关键词
Coagulopathy; Disseminated intravascular coagulation; Diagnosis; Fibrinogen; Pregnancy;
D O I
暂无
中图分类号
学科分类号
摘要
Japanese obstetrical hemorrhage recommendations state that not only pregnant women with an obstetrical disseminated intravascular coagulation (DIC) score ≥ 8 points but also those with fibrinogen levels ≤ 1.5 g/L have a high risk of maternal death and warrant blood transfusion. Our aim was to demonstrate the potential of fibrinogen levels ≤ 1.5 g/L as predictors of a Japanese obstetrical DIC score of ≥ 8. We included 595 participants with blood loss ≥ 1000 mL during vaginal delivery or ≥ 2000 mL during cesarean delivery. The frequency and volume of red blood cell (RBC), fresh-frozen plasma, platelet concentrate (PC), and fibrinogen administration in women with a DIC score of ≥ 8 and fibrinogen levels of ≤ 1.5 g/L were significantly higher than controls (P < 0.0001). Multivariate analysis demonstrated that a score of ≥ 3 was associated with RBC or fibrinogen administration and a score of ≥ 5 was associated with PC transfusion. Fibrinogen levels ≤ 1.89 g/L and ≤ 2.44 g/L were associated with PC transfusion and fibrinogen administration, respectively. Fibrinogen levels ≤ 1.5 g/L may have similar potential to a DIC score of ≥ 8 points for detecting obstetrical DIC in Japan.
引用
收藏
页码:18 / 34
页数:16
相关论文
共 50 条
  • [21] Recombinant human soluble thrombomodulin administration improves sepsis-induced disseminated intravascular coagulation and mortality: A retrospective cohort study
    Kato T.
    Sakai T.
    Kato M.
    Hagihara M.
    Hasegawa T.
    Matsuura K.
    Nakagawa T.
    Thrombosis Journal, 11 (1)
  • [22] Real-world evidence on disseminated intravascular coagulation from Japan
    Hisamune, Ryo
    Mochizuki, Katsunori
    Yamakawa, Kazuma
    ACUTE MEDICINE & SURGERY, 2023, 10 (01):
  • [23] Surveillance of the safety and efficacy of recombinant human soluble thrombomodulin in patients with obstetrical disseminated intravascular coagulation
    Kobayashi, Takao
    Kajiki, Masahiro
    Nihashi, Katsuhito
    Honda, Goichi
    THROMBOSIS RESEARCH, 2017, 159 : 109 - 115
  • [24] The effect of recombinant human soluble thrombomodulin on renal function and mortality in septic disseminated intravascular coagulation patients with acute kidney injury: a retrospective study
    Akatsuka, Masayuki
    Masuda, Yoshiki
    Tatsumi, Hiroomi
    Sonoda, Tomoko
    JOURNAL OF INTENSIVE CARE, 2020, 8 (01)
  • [25] Lymphoma during pregnancy in Japan: a multicenter retrospective cohort study
    Onishi, Chie
    Nishikori, Momoko
    Yakushijin, Kimikazu
    Kurahashi, Shingo
    Nakazawa, Hideyuki
    Takamatsu, Yasushi
    Hashimoto, Yoshinori
    Tatetsu, Hiro
    Nawa, Yuichiro
    Yoshida, Masahiro
    Kobayashi, Tsutomu
    Oyake, Tatsuo
    Yano, Shingo
    Oride, Aki
    Suzuki, Ritsuro
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2022, 115 (03) : 382 - 390
  • [26] Factors influencing the effectiveness of recombinant human soluble thrombomodulin on disseminated intravascular coagulation: a retrospective study
    Yuki Asai
    Takanori Yamamoto
    Daisuke Kito
    Kazuya Ichikawa
    Yasuharu Abe
    Journal of Pharmaceutical Health Care and Sciences, 6
  • [27] Lymphoma during pregnancy in Japan: a multicenter retrospective cohort study
    Chie Onishi
    Momoko Nishikori
    Kimikazu Yakushijin
    Shingo Kurahashi
    Hideyuki Nakazawa
    Yasushi Takamatsu
    Yoshinori Hashimoto
    Hiro Tatetsu
    Masahiro Yuichiro Nawa
    Tsutomu Yoshida
    Tatsuo Kobayashi
    Shingo Oyake
    Aki Yano
    Ritsuro Oride
    International Journal of Hematology, 2022, 115 : 382 - 390
  • [28] Factors influencing the effectiveness of recombinant human soluble thrombomodulin on disseminated intravascular coagulation: a retrospective study
    Asai, Yuki
    Yamamoto, Takanori
    Kito, Daisuke
    Ichikawa, Kazuya
    Abe, Yasuharu
    JOURNAL OF PHARMACEUTICAL HEALTH CARE AND SCIENCES, 2020, 6 (01)
  • [29] Association of endotheliopathy with coagulofibrinolytic reactions and disseminated intravascular coagulation after trauma: a retrospective observational study
    Matsumoto, Hironori
    Annen, Suguru
    Mukai, Naoki
    Ohshita, Muneaki
    Ogawa, Shirou
    Okita, Mitsuo
    Tanabe, Tsunenori
    Takezawa, Mitsuaki
    Nakabayashi, Yuki
    Kikuchi, Satoshi
    Takeba, Jun
    Sato, Norio
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [30] Optimal Antithrombin Activity Threshold for Initiating Antithrombin Supplementation in Patients With Sepsis-Induced Disseminated Intravascular Coagulation: A Multicenter Retrospective Observational Study
    Hayakawa, Mineji
    Yamakawa, Kazuma
    Kudo, Daisuke
    Ono, Kota
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2018, 24 (06) : 874 - 883